Carregant...
Advances in Prognostic Methylation Biomarkers for Prostate Cancer
There is a major clinical need for accurate biomarkers for prostate cancer prognosis, to better inform treatment strategies and disease monitoring. Current clinically recognised prognostic factors, including prostate-specific antigen (PSA) levels, lack sensitivity and specificity in distinguishing a...
Guardat en:
Autors principals: | , , , |
---|---|
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
MDPI AG
2020-10-01
|
Col·lecció: | Cancers |
Matèries: | |
Accés en línia: | https://www.mdpi.com/2072-6694/12/10/2993 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|